| Name | 4-[(2S,3R)-3-(3,5-dioxopiperazin-1-yl)butan-2-yl]piperazine-2,6-dione |
|---|---|
| Synonyms |
meso-4,4'-(3,2-butanediyl)-bis(2,6-piperazinedione)
2,6-Piperazinedione,4,4'-(1,2-dimethyl-1,2-ethanediyl)bis-,rel C12H18N4O4 2,6-Piperazinedione,4,4'-(1,2-dimethyl-1,2-ethanediyl)bis-,(R*,S*) 2,6-Piperazinedione,4,4'-(1,2-dimethylethylene)di-,meso AjvW2 ICRF-193 |
| Description | ICRF-193 is an TopoII inhibitor. (S,S)- and (R,R)-isomers ICRF-193 make up an racemic mixture, ICRF-196 (HY-118590A). ICRF-196 can be used for the research of cancer[1]. |
|---|---|
| Related Catalog | |
| References |
| Molecular Formula | C12H18N4O4 |
|---|---|
| Molecular Weight | 282.30 |
| Exact Mass | 282.13300 |
| PSA | 105.80000 |
| Vapour Pressure | 3.48E-11mmHg at 25°C |
| Symbol |
GHS06 |
|---|---|
| Signal Word | Danger |
| Hazard Statements | H301-H317 |
| Precautionary Statements | P280-P301 + P310 |
| Personal Protective Equipment | dust mask type N95 (US);Eyeshields;Faceshields;Gloves |
| Risk Phrases | 22-43 |
| Safety Phrases | 36/37 |
| RIDADR | UN 2811 6.1/PG 3 |
| RTECS | TL6380200 |